Cyrille C. Thinnes
Ollscoil na Gaillimhe – University of Galway(IE)APC Microbiome Institute(IE)
Publications by Year
Research Areas
Gut microbiota and health, Cancer, Hypoxia, and Metabolism, Parkinson's Disease Mechanisms and Treatments, Microbial Metabolic Engineering and Bioproduction, Epigenetics and DNA Methylation
Most-Cited Works
- → Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions(2020)221 cited
- → Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials(2017)220 cited
- → Targeting histone lysine demethylases — Progress, challenges, and the future(2014)188 cited
- → 5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation(2013)163 cited
- → Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson’s Disease(2019)157 cited
- → Therapeutic targeting of oxygen-sensing prolyl hydroxylases abrogates ATF4-dependent neuronal death and improves outcomes after brain hemorrhage in several rodent models(2016)139 cited
- → Glucose Metabolism and Oxygen Availability Govern Reactivation of the Latent Human Retrovirus HTLV-1(2017)74 cited
- → Genome-Scale Metabolic Modeling of the Human Microbiome in the Era of Personalized Medicine(2021)71 cited
- → Parkinson’s disease-associated alterations of the gut microbiome can invoke disease-relevant metabolic changes(2019)46 cited
- → Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases(2015)41 cited